Delivery Order SPE2DB22D1106-SPE2DB24FFAD3

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,027.66, is a delivery order for the supply of the drug XULANE 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of December 30, 2024 and utilizes a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC1S0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,017.04 firm fixed price delivery order contract is for the supply of the drug product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a period of performance through May 8, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00...
This federal contract award, with the ID SPE2DB20D1100|SPE2DB25FY86J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,040.68 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with an ID of SPE2DB22D3009|SPE2DB24FBA74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,612.06, is a Delivery Order contract for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of July 18, 2024 and is a Firm Fixed Price arrangement. It is not designated as a set-aside...
This federal contract award, valued at $2,001.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S, with a performance period through May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $16,042.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug product XULANE 150-35 MCG/DAY PATCH 3S. It is a firm-fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not designated as a set-aside and is therefore open to general competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,168.04 delivery order contract is for the supply of the drug product XULANE 150-35 MCG/DAY PATCH 3S, and has a completion date of January 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,483.15, is a delivery order for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has a firm fixed-price pricing type and an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,637.57 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product used in healthcare. The contract has a completion date of June 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,700.17, is a Delivery Order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a firm fixed price pricing type and an ultimate completion date of December 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFAD3
    Delivery Order

This federal contract award, SPE2DB22D1106|SPE2DB24FFAD3, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,547.50, is a delivery order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. It has a firm fixed price and an ultimate completion date of July 3, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:10 AM